TG Therapeutics Inc (TGTX) reports impressive growth in BRIUMVI sales and raises its full-year revenue outlook, despite ...

Greetings, and welcome to TG Therapeutics First Quarter Conference Call and Webcast. At this time, all participants are in a ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

A targeted therapy is one that has been developed to affect a specific target, such as an enzyme or receptor. Targeted therapies can either block or increase the function of their target in order ...